#PascalSoriot
LightNews LightNews
4040rec.bsky.social
#PharmaPhorum #pharma #pharmaceuticals #MandA #AstraZeneca #AZ #BristolMyersSquibb #BMS #pharmanews #AZBMSmegamerger #megamerger #Reuters #FinancialTimes #pharmaceuticalpipeline #patentcliff #shareholders #LondonStockExchange #NYSE #PascalSoriot

pharmaphorum.com/news/sources...
Sources quash rumours of an AZ/BMS mega-merger
A media report suggests there is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb.
pharmaphorum.com
August 7, 2026 at 11:42 AM
4040rec.bsky.social
#pharma #pharmaceuticals #mergers #acquisitions #M&A #AstraZeneca #AZ #BristolMyersSquibb #BMS #Pharmanews #Sales #Marketing #megamerger #FinancialTimes #bigpharma #Celgene #AbbVie #Allergan #Pfizer #Seagen #Alexion #NewYorkStockExchange #FTSE100index #PascalSoriot
zurl.co/qzJkg
Are we about to see a return for the pharma mega-merger?
There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.
pharmaphorum.com
August 4, 2026 at 10:40 AM
nile11.bsky.social
AstraZeneca Explores Potential Acquisition of Bristol Myers Squibb in Landmark Pharma Deal
#alexionPharmaceuticals #astrazenecaPlc #breyanzi #bristolMyersSquibbCo. #camzyos #celgeneCorp. #eliquis #financialTimes #opdivo #pascalSoriot
#nile1
AstraZeneca Explores Potential Acquisition of Bristol Myers Squibb in Landmark Pharma Deal
AstraZeneca Plc has conducted preliminary acquisition discussions with Bristol Myers Squibb Co. regarding a potential megadeal that would combine two of the
nile1.com
August 2, 2026 at 9:46 PM
4040rec.bsky.social
#AstraZeneca #PascalSoriot #cancertherapies #oncologyproducts #commercialperformance #blockbusterbrands #cancer #weightloss #genetherapies #antiHER2therapy #prostatecancer #breastcancer #asthma #respiratorysyncytialvirus #RSV #RSVprophylactic #lupus #phase2trials #phase3trials
zurl.co/yLEDf
AstraZeneca raises guidance on stellar cancer drugs growth
AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron
pharmaphorum.com
February 16, 2026 at 2:36 PM
4040rec.bsky.social
#bigpharma #AstraZeneca #AstraZenecaAGM #PascalSoriot #FTSE100 #UKgovernment #USAtariffs #MichelDemaré #pharmaceuticalsales #respiratory #immunology #newproductlaunches #vaccines #China #UStariffs #pharmaceuticalsupplychains #shareprice #performancetargets
www.theguardian.com/business/202...
China, America and pay inject drama into AstraZeneca’s AGM
The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year
www.theguardian.com
April 7, 2025 at 1:24 PM
fetchfeeds.bsky.social
Pascal Soriot, top executive at AstraZeneca, may leave. This would affect LSE and possibly change the UK gov't industrial strategy. #PascalSoriot #AstraZeneca https://fefd.link/n1Ti3
July 3, 2025 at 12:10 PM
pharmaphorum.bsky.social
#AstraZeneca chief executive #PascalSoriot is considering moving the company's #stockexchange listing from the UK to the US – and potentially even its domicile – according to an unconfirmed media report.
AstraZeneca CEO Soriot said to be looking at US listing
AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US.
buff.ly
July 2, 2025 at 11:30 AM
news-feed.bsky.social
@AlArabiya_Eng: #AstraZeneca CEO #PascalSoriot said reports of his imminent departure are “fake news” and he feels fit enough to spend another five years at the UK drugmaker.

https://t.co/dkPTeqUXgv
October 25, 2023 at 9:01 AM